COVID-19 Resources

Enabling the discovery of vaccines and anti-viral therapeutics against SARS-CoV-2

Virology Experience

Deep expertise in virology is at the core of Integral Molecular’s 20-year history. Our technologies and R&D services enable over 300 companies working in vaccine research and drug discovery, and have been published in over 200 peer-review publications including in Cell, Science, and Nature. Scientists at Integral Molecular have been on the forefront of combatting viral epidemics including Zika, Ebola, Chikungunya, and now SARS-CoV-2.

Upcoming Webinar

Join our virologists for an interactive webinar to learn more about using SARS-CoV-2 RVPs to detect neutralizing antibodies May 12, 2020 | 11am ET
DSCF1514

Ready To Get Started?

We have worked with more than 300 top biotech and pharmaceutical companies to help them succeed. Let's talk about how we can help you.
Or call (215) 966-6061